In some studies it has been shown that pioglitazone prevents endothelial dysfunction, most of those studies are in vitro. It is expected that such an action is carried in vivo also.
At present there is no hardcore data to support that Pioglitazone helps in combating endothelial dysfunction but they are good drug to start with in young diabetics in early state